Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 62 articles:
HTML format



Single Articles


    September 2024
  1. AHADOVA A, Kloor M
    Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer Development.
    N Engl J Med. 2024 Sep 25. doi: 10.1056/NEJMcibr2406393.
    PubMed    


    July 2024
  2. FAKIH MG, Chao J
    Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.
    N Engl J Med. 2024;391:187.
    PubMed    


  3. FOJO T
    Sotorasib in KRAS-Mutated Colorectal Cancer.
    N Engl J Med. 2024;391:186-187.
    PubMed    


    June 2024
  4. IMPERIALE TF, Porter K, Limburg PJ
    Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
    N Engl J Med. 2024;390:2225.
    PubMed    


  5. CHUNG DC, Raymond VM, Grady WM
    Stool and Blood DNA Tests for Colorectal Cancer Screening. Reply.
    N Engl J Med. 2024;390:2224-2225.
    PubMed    


  6. MANNUCCI A, Goel A
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2224.
    PubMed    


  7. SAFARI F, Noursina A, Rouzbahani S
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2223-2224.
    PubMed    


  8. MATUCHANSKY C
    Stool and Blood DNA Tests for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:2222-2223.
    PubMed    


  9. CERCEK A
    Neoadjuvant Treatment of Mismatch Repair-Deficient Colon Cancer - Clinically Meaningful?
    N Engl J Med. 2024;390:2024-2025.
    PubMed    


  10. CHALABI M, Verschoor YL, Tan PB, Balduzzi S, et al
    Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.
    N Engl J Med. 2024;390:1949-1958.
    PubMed     Abstract available


    April 2024
  11. MARIN-ESTEBAN V, Molet L, Lagana M, Ciocan D, et al
    CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.
    N Engl J Med. 2024;390:1339-1341.
    PubMed    


    March 2024
  12. LO YMD
    Cell-free DNA for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1047-1050.
    PubMed    


  13. CARETHERS JM
    Improving Noninvasive Colorectal Cancer Screening.
    N Engl J Med. 2024;390:1045-1046.
    PubMed    


  14. IMPERIALE TF, Porter K, Zella J, Gagrat ZD, et al
    Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:984-993.
    PubMed     Abstract available


  15. CHUNG DC, Gray DM 2nd, Singh H, Issaka RB, et al
    A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
    N Engl J Med. 2024;390:973-983.
    PubMed     Abstract available


    December 2023
  16. YAEGER R
    Combination Therapy and Appropriate Dosing to Target KRAS in Colorectal Cancer.
    N Engl J Med. 2023;389:2197-2199.
    PubMed    


    October 2023
  17. SCHRAG D
    Preoperative Treatment of Locally Advanced Rectal Cancer. Reply.
    N Engl J Med. 2023;389:1631-1632.
    PubMed    


  18. SEBAG-MONTEFIORE D, Cervantes A, Rodel C
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1631.
    PubMed    


  19. SHAH N
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:1630-1631.
    PubMed    


  20. FAKIH MG, Salvatore L, Esaki T, Modest DP, et al
    Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2023 Oct 22. doi: 10.1056/NEJMoa2308795.
    PubMed     Abstract available


    August 2023
  21. SACHER A, LoRusso P, Patel MR, Miller WH Jr, et al
    Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
    N Engl J Med. 2023;389:710-721.
    PubMed     Abstract available


    July 2023
  22. DOSSA F, Baxter NN
    Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:375-377.
    PubMed    


  23. SCHRAG D, Shi Q, Weiser MR, Gollub MJ, et al
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:322-334.
    PubMed     Abstract available


  24. TABERNERO J, Fakih M, Prager GW
    Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
    N Engl J Med. 2023;389:190-191.
    PubMed    


  25. VAN DE HAAR J, Valeri N, Voest EE
    Third-Line Therapy in Metastatic Colorectal Cancer.
    N Engl J Med. 2023;389:190.
    PubMed    


    May 2023
  26. YEKU OO, Longo DL
    Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer.
    N Engl J Med. 2023;388:1711-1714.
    PubMed    


  27. PRAGER GW, Taieb J, Fakih M, Ciardiello F, et al
    Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
    N Engl J Med. 2023;388:1657-1667.
    PubMed     Abstract available


    March 2023
  28. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    PubMed     Abstract available


    January 2023
  29. DOMINITZ JA, Robertson DJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:379.
    PubMed    


  30. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    PubMed    


  31. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    PubMed    


  32. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    PubMed    


  33. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    PubMed    


  34. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    PubMed    


  35. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    PubMed    


    December 2022
  36. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    PubMed     Abstract available


    November 2022
  37. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    PubMed    


    October 2022
  38. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    PubMed    


  39. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed     Abstract available


    September 2022
  40. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    PubMed    


  41. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    PubMed    


  42. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    PubMed    


    August 2022
  43. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    PubMed    


  44. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    PubMed    


  45. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    PubMed    


  46. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    PubMed    


  47. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    PubMed    


  48. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    PubMed    


  49. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    PubMed    


    July 2022
  50. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed    


  51. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed    


  52. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed    


    June 2022
  53. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    PubMed    


  54. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    PubMed     Abstract available


  55. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available


  56. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    PubMed    


  57. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed     Abstract available


  58. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    PubMed    


    April 2022
  59. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    PubMed    


    February 2022
  60. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    PubMed    


  61. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    


    January 2022
  62. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.